Press Releases
Press Release
Oxford Drug Design receives over £8m in grant and equity investment
Oxford Drug Design (ODD) wins major funding awards from CARB-X, the UK Department of Health and Social Care (DHSC) and an equity investment led by o2h Ventures totaling over £8m to develop new antibio...
Press Release
The o2h Therapeutics and AI Fund makes investment in early stage biotechnology company
Cambridge, UK, 28 March 2019. The o2h Therapeutics Fund & AI (“The Fund”), an early stage S/EIS fund investing in biotechnology therapeutic and related AI opportunities, is pleased to announce an inve...